The Lind Partners
The Lind Partners is a New York-based alternative asset management firm.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed The Lind Partners Information
Geographic Data
Address: 370 Lexington Avenue
City: New York
State: NY
Zip: 10017
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$38M
Social
Twitter
Linkedin
Crunchbase
Metrics
1,882,714Website Global Rank
11,611Website Monthly Traffic
Twitter Followers
Description
At Lind, they understand the challenges faced by management teams of growing companies. By upholding their mission to be a responsible investor and a reliable financial partner, they have built a reputation as a leading provider of growth capital to the small- and mid-cap sector. The Lind Partners is a New York-based alternative asset management firm that manages a family of institutional investment funds focused on small- and mid-cap publicly traded companies with an emphasis on Australia, Canada and the United Kingdom. Since 2009, the core team at Lind has worked on over 75 direct investments with a total transaction value in excess of $550 million.
Contact Phone:
+16467017421
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2021 | COMSovereign | Post-IPO Equity | 10M |
| 12/2022 | ELSE Nutrition | Post-IPO Equity | 4.3M |
| 12/2019 | Boxlight | Post-IPO Equity | 0 |
| 1/2018 | Avalon Advanced Materials | Post-IPO Equity | 1.5M |
| 1/2017 | Identitii | Venture Round | - |
| 11/2021 | Seelos Therapeutics | Post-IPO Debt | 20M |
| 7/2019 | Noxopharm | Post-IPO Debt | 17.9M |
| 8/2021 | Magnis Energy Technologies | Post-IPO Debt | 0 |
| 9/2022 | Bragg | Post-IPO Debt | 8.7M |
| 6/2021 | Bioasis Technologies | Post-IPO Debt | 0 |
| 8/2021 | Appili Therapeutics | Post-IPO Equity | 0 |
| 2/2017 | Vamp | Venture Round | - |
| 2/2023 | PaxMedica | Post-IPO Debt | 3.7M |
| 2/2023 | PaxMedica | Post-IPO Equity | 3.2M |
| 11/2021 | Seelos Therapeutics | Post-IPO Debt | 0 |
| 8/2021 | Appili Therapeutics | Post-IPO Equity | 0 |
| 8/2021 | Magnis Energy Technologies | Post-IPO Debt | 0 |
| 6/2021 | Bioasis Technologies | Post-IPO Debt | 0 |
| 5/2021 | COMSovereign | Post-IPO Debt | 0 |
| 12/2019 | Boxlight | Post-IPO Equity | 0 |
| 7/2019 | Noxopharm | Post-IPO Debt | 0 |
| 1/2018 | Avalon Advanced Materials | Post-IPO Equity | 0 |
| 2/2017 | Vamp | Venture Round | - |
| 1/2017 | Identitii | Venture Round | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
